Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'development drug'
development drug published presentations and documents on DocSlides.
STEPS TAKEN TO RESPOND TO THE
by karlyn-bohler
2014 RECOMMENDATIONS. STEERING AND FOLLOW-UP COMM...
SMEs in IMI2 Calls for Proposals
by lois-ondreau
Why should an SME participate in an . IMI project...
Antibiotic resistance: Global problem – local challenges
by luanne-stotts
Ildiko. . Kustos. Medical Microbiology Consultan...
Patient Engagement in Drug Development
by debby-jeon
:. Experiences, Good Practices and Lessons Learne...
Standards-Setting in the Context of Regulatory Harmonization
by debby-jeon
Carolyn Compton, M.D., Ph.D.,. CEO and . Presiden...
Faculty Leonard H. Calabrese, DO
by trish-goza
Professor of Medicine. Cleveland Clinic Lerner Co...
Rectal Microbicides: Where We’re Heading
by giovanna-bartolotta
Craig Hendrix, MD. Johns Hopkins University. Micr...
Michael Wong, MD Sr. Medical Director, Infectious Diseases
by test
Sarepta. Therapeutics. Associate Professor of Me...
THE BRAIN MODEL OF ADDICTION
by pamella-moone
Drug Court Conference. Normal, OK. September, 201...
The Adolescent in society
by liane-varnes
Chapter 6. Adolescence in our society. Adolescenc...
Session 23: The Option to delay
by myesha-ticknor
‹#›. Aswath Damodaran. 1. The Option to Delay...
1 MEMS Technology Development for Unmet Medical Needs
by jane-oiler
by. Tim Stucchi . Sensera. Operations Manager. 2...
Building a New Biotech Enterprise
by aaron
Pravin. R. . Chaturvedi. , Ph.D.. Pivot Pharmace...
Committed to Becoming a Leader in Topical Drug Development
by mitsue-stanley
Pennsylvania Biotechnology Center. 3805 . Old Eas...
Type I / Type II Error Control in Drug Development
by luanne-stotts
Andy Grieve. Head of Centre of Excellence. for St...
Precision Medicine
by trish-goza
From Promise to Practice. PRECISION ONCOLOGY IS T...
NIDA Director’s Report to the
by min-jolicoeur
CRAN Joint Council Meeting. May 3, 2017. Nora ...
ADVANCED WORKSHOP : REVIEW OF DRUG DEVELOPMENT IN BANGKOK, 2-6 FEB 200
by lindy-dunigan
International Conferenceon Harmonisation of Techni...
Regulatory requirements for
by tawny-fly
- . Drug/Device . Combination . Products. - Medic...
Laboratory and Clinical Services
by conchita-marotz
Staff number grew from 1 to . 500+. 15+ Years of ...
Relationship and Addiction
by conchita-marotz
Gary Broderick. SAOL Project. Relationship . “T...
Pharmaceutical Quality Control &
by debby-jeon
current Good Manufacturing Practice. PHT 436. Lec...
Duchenne Parent Project.NL /PPMD . USA
by natalia-silvester
. Orlando, Florida 1994. Basic Principles:. As...
reaction by-products. During drug product development, impurities may
by giovanna-bartolotta
4 PHARMACEUTICAL IMPURITY ANALYSIS
Current Opinion in Drug Discovery & Development
by lois-ondreau
REVIEW 2009 12 (4):509-518
Stability Studies - Evaluation of Outcomes and Development
by tatyana-admore
of . Documentation For Regulatory Submissions. Bo...
1 March 2013
by cheryl-pisano
Day . two of the . 1. st. Test . in . Dunedin, N...
The Belfast Youth Development Study:
by olivia-moreira
A longitudinal study of adolescence. The Sample. ...
Partnering drug discovery and development
by olivia-moreira
VisionToEmergeasleadingplayerprovidingfullspectrum...
A new approach to drug discovery and development
by cheryl-pisano
Selective replacement of hydrogen atoms with deu h...
PSYB3: child development and applied options
by conchita-marotz
Substance abuse. Drugs – I never touch them!. W...
Joining
by mitsue-stanley
Private and Public Forces to Boost . Innovation i...
Pubrica UK Regulatory Submission Writing for Clinical Research
by Pubrica106
Pubrica offers Regulatory Submission Writing with ...
Development & The US FDA Approval of Generic Drugs
by lois-ondreau
Development & The US FDA Approval of Generic Drugs...
Load More...